RHOA and systemic lupus erythematosus: The RhoA/ROCK signaling pathway has been implicated in immunoinflammatory diseases, such as systemic lupus erythematosus [30], myasthenia gravis [31], inflammatory cardiovascular diseases [32], and inflammatory airways diseases [33].